Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus

Journal of General Virology

Volumn 92, Issue 9, 2011, Pages 2122-2132

  Scott, Paul D ^a   Meng, Bo ^a   Marriott, Anthony C ^a   Easton, Andrew J ^a   Dimmock, Nigel J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEFECTIVE VIRUS; FEMALE; GENOME; IN VIVO STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INNATE IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY TRACT DISEASE;

ANIMALS; CROSS PROTECTION; DEFECTIVE VIRUSES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNITY, INNATE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INTERFERON TYPE I; MALE; MICE; ORTHOMYXOVIRIDAE INFECTIONS; RODENT DISEASES;

CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA B VIRUS (B/LEE/40); MUS; ORTHOMYXOVIRIDAE; PARAMYXOVIRIDAE;

EID: 80051765327     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.034132-0     Document Type: Article

References (40)

1. Barrett, A. D. T. & Dimmock, N. J. (1984). Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus. J Infect Dis 150, 98-104.
2. Barrett, A. D. T. & Dimmock, N. J. (1986). Defective interfering viruses and infections of animals. Curr Top Microbiol Immunol 128, 55-84.
3. Barrett, A. D. T., Guest, A. R., Mackenzie, A. & Dimmock, N. J. (1984). Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication. J Gen Virol 65, 1909-1920.
4. Baum, A., Sachidanandam, R. & García-Sastre, A. (2010). Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc Natl Acad Sci U S A 107, 16303-16308.
5. Dimmock, N. J. (1991). The biological significance of defective interfering viruses. Rev Med Virol 1, 165-176.
6. Dimmock, N. J. (1996). Antiviral activity of defective interfering influenza virus in vivo. In Viral and Other Infections of the Respiratory Tract, pp. 421-445.
7. Edited by S. Myint & D. Taylor-Robinson. London: Chapman & Hall. Dimmock, N. J. & Marriott, A. C. (2006). In vivo antiviral activity: defective interfering virus protects better against virulent Influenza A virus than avirulent virus. J Gen Virol 87, 1259-1265.
8. Dimmock, N. J., Beck, S. & McLain, L. (1986). Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication. J Gen Virol 67, 839-850.
9. Dimmock, N. J., Rainsford, E. W., Scott, P. D. & Marriott, A. C. (2008). Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 82, 8570-8578.
10. Duhaut, S. D. & Dimmock, N. J. (1998). Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Virology 248, 241-253.
11. Duhaut, S. & Dimmock, N. J. (2000). Approximately 150 nucleotides from the 59 end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells. Virology 275, 278-285.
12. Duhaut, S. D. & Dimmock, N. J. (2002). Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 59 sequence: evidence from a plasmiddriven system. J Gen Virol 83, 403-411.
13. Duhaut, S. D. & Dimmock, N. J. (2003). Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease. J Virol Methods 108, 75-82.
14. Easton, A. J., Scott, P. D., Edworthy, N. L., Meng, B., Marriott, A. C. & Dimmock, N. J. (2011). A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine 29, 2777-2784.
15. Frey, T. K., Jones, E. V., Cardamone, J. J., Jr & Youngner, J. S. (1979). Induction of interferon in L cells by defective-interfering (DI) particles of vesicular stomatitis virus: lack of correlation with content of [±] snapback RNA. Virology 99, 95-102.
16. Gidlund, M., Örn, A., Wigzell, H., Senik, A. & Gresser, I. (1978). Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273, 759-761.
17. Holland, J. J. (1990a). Defective viral genomes. In Virology, 2nd edn, pp. 151-165.
18. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press. Holland, J. J. (1990b). Generation and replication of defective viral genomes. In Virology, 2nd edn, pp. 77-99.
19. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press. Horimoto, T., Takada, A., Iwatsuki-Horimoto, K., Hatta, M., Goto, H. & Kawaoka, Y. (2003). Generation of influenza A viruses with chimeric (type A/B) hemagglutinins. J Virol 77, 8031-8038.
20. Huang, A. S. & Baltimore, D. (1970). Defective viral particles and viral disease processes. Nature 226, 325-327.
21. Jackson, D., Cadman, A., Zurcher, T. & Barclay, W. S. (2002). A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J Virol 76, 11744-11747.
22. Jewell, N. A., Cline, T., Mertz, S. E., Smirnov, S. V., Flaño, E., Schindler, C., Grieves, J. L., Durbin, R. K., Kotenko, S. V. & Durbin, J. E. (2010). Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84, 11515-11522.
23. Kaverin, N. V., Varich, N. L., Sklyanskaya, E. I., Amvrosieva, T. V., Petrik, J. & Vovk, T. C. (1983). Studies on heterotypic interference between influenza A and B viruses: a differential inhibition of the synthesis of viral proteins and RNAs. J Gen Virol 64, 2139-2146.
24. Marcus, P. I. & Gaccione, C. (1989). Interferon induction by viruses. XIX. Vesicular stomatitis virus-New Jersey: high multiplicity passages generate interferon-inducing, defective-interfering particles. Virology 171, 630-633.
25. Marcus, P. I. & Sekellick, M. J. (1977). Defective interfering particles with covalently linked [±]RNA induce interferon. Nature 266, 815-819.
26. Mikheeva, A. V. & Ghendon, Y. Z. (1982). Intrinsic interference between influenza A and B viruses. Arch Virol 73, 287-294.
27. Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J. C., Paludan, S. R., Klucher, K. & Staeheli, P. (2008). Interferon-l contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4, e1000151.
28. Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D. & other authors (2010). Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84, 5670-5677.
29. Morgan, D. J. & Dimmock, N. J. (1992). Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse. J Virol 66, 1188-1192.
30. Nayak, D. P. (1980). Defective interfering influenza viruses. Annu Rev Microbiol 34, 619-644.
31. Nayak, D. P., Chambers, T. M. & Akkina, R. K. (1985). Defectiveinterfering (DI) RNAs of influenza viruses: origin, structure, expression, and interference. Curr Top Microbiol Immunol 114, 103-151.
32. Nayak, D. P., Chambers, T. M. & Akkina, R. M. (1989). Structure of defective-interfering RNAs of influenza virus and their role in interference. In The Influenza Viruses, pp. 269-317.
33. Edited by R. M. Krug. New York: Plenum Press. Noble, S. & Dimmock, N. J. (1994). Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus. J Gen Virol 75, 3485-3491.
34. Noble, S., McLain, L. & Dimmock, N. J. (2004). Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. Vaccine 22, 3018-3025.
35. Perrault, J. (1981). Origin and replication of defective interfering particles. Curr Top Microbiol Immunol 93, 151-207
36. Roux, L., Simon, A. E. & Holland, J. J. (1991). Effects of defective interfering viruses on virus replication and pathogenesis in vitro and in vivo. Adv Virus Res 40, 181-211.
37. Sekellick, M. J. & Marcus, P. I. (1982). Interferon induction by viruses. VIII. Vesicular stomatitis virus: [±]DI-011 particles induce interferon in the absence of standard virions. Virology 117, 280-285.
38. Strahle, L., Garcin, D. & Kolakofsky, D. (2006). Sendai virus defectiveinterfering genomes and the activation of interferon-b. Virology 351, 101-111.
39. Tobita, K., Tanaka, T., Goto, H. & Feng, S.-Y. (1983). Temperature-sensitive influenza A virus clones originated by a cross between A/Aichi/2/68 (H3N2) and B/Yamagata/1/73. Arch Virol 75, 17-27.
40. Wunderlich, K., Juozapaitis, M., Mänz, B., Mayer, D., Götz, V., Zöhner, A., Wolff, T., Schwemmle, M. & Martin, A. (2010). Limited compatibility of polymerase subunit interactions in influenza A and B viruses. J Biol Chem 285, 16704-16712